Emerging fields include circadian gene expression, intermittent fasting, time-restricted feeding, endothelial nitric oxide synthase, and gut microbiota, with therapeutic targets in circadian rhythms offering promising prospects for obesity treatment. Here, NOS3 is linked to obesity disorder.